{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Orthomyxoviridae+Infection&page=29", "query": { "condition": "Orthomyxoviridae Infection", "page": 29 }, "page_size": 10 }, "pagination": { "page": 29, "page_size": 10, "total_count": 931, "total_pages": 94, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Orthomyxoviridae+Infection&page=30&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Orthomyxoviridae+Infection&page=28&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-17T04:21:53.747Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05375838", "title": "A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "SARS-CoV-2", "Influenza" ], "interventions": [ { "name": "mRNA-1073", "type": "BIOLOGICAL" }, { "name": "mRNA-1010", "type": "BIOLOGICAL" }, { "name": "mRNA-1273", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "ModernaTX, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 550, "start_date": "2022-05-13", "completion_date": "2022-12-29", "has_results": true, "last_update_posted_date": "2024-02-28", "last_synced_at": "2026-10-17T04:21:53.747Z", "location_count": 14, "location_summary": "Hollywood, Florida • Peoria, Illinois • Sioux City, Iowa + 9 more", "locations": [ { "city": "Hollywood", "state": "Florida" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Sioux City", "state": "Iowa" }, { "city": "Metairie", "state": "Louisiana" }, { "city": "Norfolk", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT05375838" }, { "nct_id": "NCT01747148", "title": "Testing the AVI-7100 Flu Drug in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "AVI-7100 versus placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 66, "start_date": "2012-12-08", "completion_date": "2016-06-29", "has_results": false, "last_update_posted_date": "2017-12-26", "last_synced_at": "2026-10-17T04:21:53.747Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01747148" }, { "nct_id": "NCT02015494", "title": "Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "VAX2012Q", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "VaxInnate Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 316, "start_date": "2014-03", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2015-03-06", "last_synced_at": "2026-10-17T04:21:53.747Z", "location_count": 4, "location_summary": "Lenexa, Kansas • Rochester, New York • Mt. Pleasant, South Carolina + 1 more", "locations": [ { "city": "Lenexa", "state": "Kansas" }, { "city": "Rochester", "state": "New York" }, { "city": "Mt. Pleasant", "state": "South Carolina" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02015494" }, { "nct_id": "NCT00958126", "title": "A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "CSL425", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Seqirus", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1313, "start_date": "2009-08", "completion_date": "2010-04", "has_results": true, "last_update_posted_date": "2017-11-21", "last_synced_at": "2026-10-17T04:21:53.747Z", "location_count": 11, "location_summary": "Huntsville, Alabama • San Diego, California • Melbourne, Florida + 8 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Peoria", "state": "Illinois" }, { "city": "South Bend", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00958126" }, { "nct_id": "NCT03186781", "title": "Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "VRC-FLUNPF081-00-VP (HA-F A/Sing)", "type": "BIOLOGICAL" }, { "name": "VRC-FLUDNA082-00-VP (DNA A/Sing)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 50, "start_date": "2017-10-25", "completion_date": "2019-09-03", "has_results": true, "last_update_posted_date": "2021-06-16", "last_synced_at": "2026-10-17T04:21:53.747Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03186781" }, { "nct_id": "NCT01388439", "title": "Pharmacokinetics of Oseltamivir in Newborns and Infants", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Prematurity of Fetus" ], "interventions": [ { "name": "Oseltamivir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "St. Louis Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "6 Months", "sex": "ALL", "summary": "Up to 6 Months" }, "enrollment_count": 19, "start_date": "2011-01", "completion_date": "2011-01", "has_results": false, "last_update_posted_date": "2011-07-06", "last_synced_at": "2026-10-17T04:21:53.747Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01388439" }, { "nct_id": "NCT01317745", "title": "H5N1 Mix and Match With MF59", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Phosphate Buffered Saline (PBS) diluent", "type": "OTHER" }, { "name": "MF59 Adjuvant", "type": "DRUG" }, { "name": "H5N1 Antigen", "type": "BIOLOGICAL" } ], "intervention_types": [ "OTHER", "DRUG", "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 270, "start_date": "2011-05", "completion_date": "2012-09", "has_results": false, "last_update_posted_date": "2013-01-25", "last_synced_at": "2026-10-17T04:21:53.747Z", "location_count": 5, "location_summary": "Atlanta, Georgia • Decatur, Georgia • Iowa City, Iowa + 2 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Decatur", "state": "Georgia" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01317745" }, { "nct_id": "NCT06695130", "title": "Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "COVID-19 Immunization", "Influenza Immunization" ], "interventions": [ { "name": "RIV (recombinant influenza vaccine)", "type": "BIOLOGICAL" }, { "name": "rC19 (dose 1)", "type": "BIOLOGICAL" }, { "name": "RIV + rC19 (dose 1)", "type": "BIOLOGICAL" }, { "name": "RIV + rC19 (dose 2)", "type": "BIOLOGICAL" }, { "name": "RIV + rC19 (dose 3)", "type": "BIOLOGICAL" }, { "name": "RIV + rC19 (dose 4)", "type": "BIOLOGICAL" }, { "name": "Placebo (0.9% NaCl)", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 980, "start_date": "2024-11-18", "completion_date": "2026-04-03", "has_results": false, "last_update_posted_date": "2026-05-05", "last_synced_at": "2026-10-17T04:21:53.747Z", "location_count": 12, "location_summary": "Phoenix, Arizona • Cerritos, California • Vista, California + 9 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Cerritos", "state": "California" }, { "city": "Vista", "state": "California" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06695130" }, { "nct_id": "NCT04164212", "title": "Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Flumist Quadrivalent Nasal Product", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 33, "start_date": "2020-09-01", "completion_date": "2026-01-22", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-17T04:21:53.747Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT04164212" }, { "nct_id": "NCT01196975", "title": "A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Quadrivalent seasonal influenza vaccine GSK2282512A", "type": "BIOLOGICAL" }, { "name": "FluLavalTM-VB", "type": "BIOLOGICAL" }, { "name": "FluLavalTM-YB", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1707, "start_date": "2010-10-01", "completion_date": "2011-06-24", "has_results": true, "last_update_posted_date": "2018-09-21", "last_synced_at": "2026-10-17T04:21:53.747Z", "location_count": 6, "location_summary": "Mesa, Arizona • Wichita, Kansas • Elkridge, Maryland + 3 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Elkridge", "state": "Maryland" }, { "city": "Endwell", "state": "New York" }, { "city": "Jefferson Hills", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01196975" } ] }